The researchers found that there may be a dose-dependent negative correlation between caffeine and all-cause mortality, compared with the lowest quintile of caffeine intake, and the second, third and Individuals with the highest quartile of caffeine intake were at 12%, 22%, and 24% less likely to die of death, respectively.
Recently, at the 2017 American Society of Nephrology Kidney Week, researchers from Portugal said that caffeine intake may prolong the life of patients with chronic kidney disease (CKD). In the general population caffeine intake is directly related to the body longevity, in order to observe whether this effect is also present in patients with kidney disease, the researchers through a prospective cohort of 2328 CKD patients to observe the intake of coffee Due to their relationship with participants' mortality rates, these participants participated in the country's continuous health and nutrition survey between 1999 and 2010.
The researchers found that there may be a dose-dependent negative correlation between caffeine and all-cause mortality, with the second, third and top quartiles compared to the lowest quartile caffeine intake Individuals with a median caffeine intake reduced the risk of death by 12%, 22%, and 24%, respectively.
Dr. Bigotte Vieira, a researcher, said our study illustrates a dose-dependent protective effect between caffeine intake and mortality in patients with chronic kidney disease that does not depend on a number of potential factors, including Age, sex, race, annual household income, education level, approximate GFR, creatinine ratio, hypertension, smoking status, dyslipidemia, body mass index, previous cardiovascular events and diet Ingestion, Carbohydrates, Polyunsaturated Fatty Acids & Fibers).
The authors conclude that the results of this study suggest that more people who take chronic kidney disease may be caffeinated or reduce their mortality, perhaps suggesting a simple and clinically useful option, although the researchers believe this is the most Good is confirmed in randomized clinical trials, they believe that observational studies do not explain that caffeine can reduce the risk of death in patients with chronic kidney disease, but this only hinted the possibility of such protective effects.
Email : kdtinchina@yahoo.com
Online doctor : 008615931093124
